Enterprise Value:
$1.93B-$34.92M(-1.77%)Summary
- As of today, RXRX enterprise value is $1.93 billion, with a fall of -$34.92 million (-1.77%) during the most recent trading session on November 3, 2025.
 - Over the past year, RXRX enterprise value has increased by +$438.76 million (+29.33%).
 - RXRX enterprise value is now -69.45% below its all-time high of $6.33 billion.
 
Performance
RXRX Enterprise Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Enterprise Value Formula
Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents
RXRX Enterprise Value Trends
| PeriodPeriod | Enterprise ValueEnterprise Value | Market CapMarket Cap | PricePrice | 
|---|---|---|---|
| 1D1 Day | -1.8% | -1.4% | -1.4% | 
| 1M1 Month | -1.1% | -0.9% | -0.9% | 
| 3M3 Months | -4.5% | -3.7% | -4.2% | 
| 6M6 Months | +1.5% | +2.5% | -4.6% | 
| YTDYTD | -11.7% | -11.4% | -19.5% | 
| 1Y1 Year | +29.3% | +29.4% | -15.0% | 
| 5Y5 Years | - | - | - | 
RXRX Enterprise Value Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | $2.52B | -23.4% | $1.84B | +5.0% | 
| 3M | 3-Month | $2.52B | -23.4% | $1.53B | +26.2% | 
| 6M | 6-Month | $2.52B | -23.4% | $1.25B | +55.0% | 
| 1Y | 1-Year | $3.88B | -50.1% | $1.20B | +61.1% | 
| 3Y | 3-Year | $3.88B | -50.1% | $456M | +324.5% | 
| 5Y | 5-Year | $6.33B | -69.5% | $326M | +492.7% | 
| All-Time | All-Time | $6.33B | -69.5% | $326M | +492.7% | 
RXRX Enterprise Value History
| Date | Value | 
|---|---|
| 2025 | $1.93B(-11.7%)  | 
| 2024 | $2.19B(+11.7%)  | 
| Date | Value | 
|---|---|
| 2023 | $1.96B(+101.6%)  | 
| 2022 | $972.60M(-59.6%)  | 
| 2021 | $2.41B  | 
FAQ
- What is Recursion Pharmaceuticals, Inc. enterprise value?
 - What is the all-time high enterprise value for Recursion Pharmaceuticals, Inc.?
 - What is RXRX enterprise value year-to-date change?
 - What is Recursion Pharmaceuticals, Inc. enterprise value year-on-year change?
 
What is Recursion Pharmaceuticals, Inc. enterprise value?
The current enterprise value of RXRX is $1.93B
What is the all-time high enterprise value for Recursion Pharmaceuticals, Inc.?
Recursion Pharmaceuticals, Inc. all-time high enterprise value is $6.33B
What is RXRX enterprise value year-to-date change?
Recursion Pharmaceuticals, Inc. enterprise value has changed by -$256.79M (-11.72%) since the beginning of the year
What is Recursion Pharmaceuticals, Inc. enterprise value year-on-year change?
Over the past year, RXRX enterprise value has changed by +$438.76M (+29.33%)